Ion channel remodelling in atrial fibrillation

European Cardiology

Volumn 7, Issue 2, 2011, Pages 97-103

  Voigt, Niels ^a   Dobrevu, Dobromir ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Atrial fibrillation; Ion channels; Mechanisms; Remodelling

Indexed keywords

2' (4 METHOXYPHENYLACETAMIDOMETHYL) N [2 (3 PYRIDYL)ETHYL] 2 BIPHENYLCARBOXAMIDE; AMIODARONE; ANTIARRHYTHMIC AGENT; BEPRIDIL; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM CHANNEL CAV1.2; CALCIUM CHANNEL L TYPE; CALCIUM ION; CONNEXIN 40; DELAYED RECTIFIER POTASSIUM CHANNEL; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; ION CHANNEL; MUSCARINIC RECEPTOR; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL KV1.5; POTASSIUM CHANNEL KV4.3; POTASSIUM ION; RYANODINE RECEPTOR 2; SMALL CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; SODIUM CALCIUM EXCHANGE PROTEIN; SODIUM ION; TRANSIENT RECEPTOR POTENTIAL CHANNEL 3; UNCLASSIFIED DRUG;

AFTERDEPOLARIZATION; ANTIARRHYTHMIC ACTIVITY; ARRHYTHMOGENESIS; ARTICLE; CALCIUM CELL LEVEL; CALCIUM CURRENT; CALCIUM TRANSPORT; CHANNEL GATING; CHRONIC ATRIAL FIBRILLATION; DRUG SELECTIVITY; DRUG TARGETING; HEART ARRHYTHMIA; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM CONDUCTION; HEART ATRIUM FIBRILLATION; HEART DEPOLARIZATION; HEART MUSCLE REFRACTORY PERIOD; HEART REPOLARIZATION; HUMAN; NONHUMAN; OXIDATIVE STRESS; POTASSIUM CURRENT; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REENTRY ARRHYTHMIA; SARCOPLASMIC RETICULUM; SODIUM CURRENT; TRANSCRIPTION REGULATION; VAGUS NERVE STIMULATION;

EID: 84857516171     PISSN: 17583756     EISSN: 17583764     Source Type: Journal    
DOI: 10.15420/ecr.2011.7.2.97     Document Type: Article

References (128)

1. Pedersen OD, Abildstrom SZ, Ottesen MM, et al., Increased risk of sudden and non-sudden cardiovascular death in patients with atrial fibrillation/flutter following acute myocardial infarction, Eur Heart J, 2006;27:290-5.
2. Tsang TS, Miyasaka Y, Barnes ME, et al., Epidemiological profile of atrial fibrillation: a contemporary perspective, Prog Cardiovasc Dis, 2005;48:1-8.
3. Dobrev D, Nattel S, New antiarrhythmic drugs for treatment of atrial fibrillation, Lancet, 2010;375:1212-23
4. Riley MJ, Marrouche NF, Ablation of atrial fibrillation, Curr Probl Cardiol, 2006;31:361-90
5. Nattel S, Carlsson L, Innovative approaches to antiarrhythmic drug therapy, Nat Rev Drug Discov, 2006;5:1034-49
6. Nattel S, Opie LH, Controversies in atrial fibrillation, Lancet, 2006;367:262-72
7. Nattel S, Burstein B, Dobrev D, Atrial remodelling and atrial fibrillation: mechanisms and implications, Circ Arrhythm Electrophysiol, 2008;1:62-73
8. Nattel S, New ideas about atrial fibrillation 50 years on, Nature, 2002;415:219-26
9. Wijffels MC, Kirchhof CJ, Dorland R, et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats, Circulation, 1995;92:1954-68.
10. Nattel S, Maguy A, Le Bouter S, et al. Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation, Physiol Rev, 2007;87:425-56.
11. Dobrev D, Electrical remodeling in atrial fibrillation, Herz, 2006;31:108-12; quiz 142-3
12. Schotten U, Greiser M, Benke D, et al., Atrial fibrillation-induced atrial contractile dysfunction: a tachycardiomyopathy of a different sort, Cardiovasc Res, 2002;53:192-201.
13. Sun H, Gaspo R, Leblanc N, et al., Cellular mechanisms of atrial contractile dysfunction caused by sustained atrial tachycardia, Circulation, 1998;98:719-27.
14. Yeh YH, Wakili R, Qi XY, et al., Calcium-handling abnormalities underlying atrial arrhythmogenesis and contractile dysfunction in dogs with congestive heart failure, Circ Arrhythm Electrophysiol, 2008;1(2):93-102.
15. Wakili R, Yeh YH, Qi XY, et al., Multiple potential molecular contributors to atrial hypocontractility caused by atrial tachycardia remodeling in dogs, Circ Arrhythm Electrophysiol, 2010;3(5):530-41.
16. Greiser M, Neuberger HR, Harks E, et al., Distinct contractile and molecular differences between two goat models of atrial dysfunction: AV block-induced atrial dilatation and atrial fibrillation, J Mol Cell Cardiol, 2009;46:385-94.
17. Yue L, Feng J, Gaspo R, et al., Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation, Circ Res, 1997;81:512-25.
18. Van Wagoner DR, Pond AL, Lamorgese M, et al., Atrial Ltype Ca2+ currents and human atrial fibrillation, Circ Res, 1999;85:428-36.
19. Christ T, Boknik P, Wohrl S, et al., L-type Ca2+ current downregulation in chronic human atrial fibrillation is associated with increased activity of protein phosphatases, Circulation, 2004;110:2651-7.
20. Ehrlich JR, Cha TJ, Zhang L, et al., Characterization of a hyperpolarization-activated time-dependent potassium current in canine cardiomyocytes from pulmonary vein myocardial sleeves and left atrium, J Physiol, 2004;557:583-97.
21. Dobrev D, Graf E, Wettwer E, et al., Molecular basis of downregulation of G-protein-coupled inward rectifying K(+) current (I(K,ACh) in chronic human atrial fibrillation: decrease in GIRK4 mRNA correlates with reduced I(K,ACh) and muscarinic receptor-mediated shortening of action potentials, Circulation, 2001;104:2551-7.
22. Dobrev D, Friedrich A, Voigt N, et al., The G protein-gated potassium current I(K,ACh) is constitutively active in patients with chronic atrial fibrillation, Circulation, 2005;112:3697-706.
23. Cha TJ, Ehrlich JR, Chartier D, et al., Kir3-based inward rectifier potassium current: potential role in atrial tachycardia remodeling effects on atrial repolarization and arrhythmias, Circulation, 2006;113:1730-7.
24. Voigt N, Friedrich A, Bock M, et al., Differential phosphorylation-dependent regulation of constitutively active and muscarinic receptor-activated IK,ACh channels in patients with chronic atrial fibrillation, Cardiovasc Res, 2007;74:426-37.
25. Dobrev D, Nattel S, Calcium handling abnormalities in atrial fibrillation as a target for innovative therapeutics, J Cardiovasc Pharmacol, 2008;52:293-9
26. Berenfeld O, Zaitsev AV, Mironov SF, et al., Frequencydependent breakdown of wave propagation into fibrillatory conduction across the pectinate muscle network in the isolated sheep right atrium, Circ Res, 2002;90:1173-80.
27. Allessie M, Ausma J, Schotten U, Electrical, contractile and structural remodeling during atrial fibrillation, Cardiovasc Res, 2002;54:230-46
28. Burstein B, Nattel S, Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation, J Am Coll Cardiol, 2008;51:802-9
29. Duytschaever M, Blaauw Y, Allessie M, Consequences of atrial electrical remodeling for the anti-arrhythmic action of class IC and class III drugs, Cardiovasc Res, 2005;67:69-76
30. Tieleman RG, Van Gelder IC, Bosker HA, et al. Does flecainide regain its antiarrhythmic activity after electrical cardioversion of persistent atrial fibrillation?, Heart Rhythm, 2005;2:223-30.
31. Okumura Y, Watanabe I, Nakai T, et al., Recurrence of atrial fibrillation after internal cardioversion of persistent atrial fibrillation: prognostic importance of electrophysiologic parameters, Circ J, 2005;69:1514-20.
32. Sun H, Chartier D, Leblanc N, et al., Intracellular calcium changes and tachycardia-induced contractile dysfunction in canine atrial myocytes, Cardiovasc Res, 2001;49:751-61.
33. Dobrev D, New concepts in understanding and modulating atrial repolarisation in patients with atrial fibrillation, J Interv Card Electrophysiol, 2008;22:107-10
34. Qi XY, Yeh YH, Xiao L, et al., Cellular signaling underlyingatrial tachycardia remodeling of L-type calcium current, Circ Res, 2008;103:845-54.
35. Gaborit N, Steenman M, Lamirault G, et al., Human atrial ion channel and transporter subunit gene-expression remodeling associated with valvular heart disease and atrial fibrillation, Circulation, 2005;112:471-81.
36. Bosch RF, Zeng X, Grammer JB, et al., Ionic mechanisms of electrical remodeling in human atrial fibrillation, Cardiovasc Res, 1999;44:121-31.
37. Sossalla S, Kallmeyer B, Wagner S, et al., Altered Na(+) currents in atrial fibrillation effects of ranolazine on arrhythmias and contractility in human atrial myocardium, J Am Coll Cardiol, 2010;55:2330-42.
38. Bosch RF, Scherer CR, Rub N, et al., Molecular mechanisms of early electrical remodeling: transcriptional downregulation of ion channel subunits reduces I(Ca,L) and I(to) in rapid atrial pacing in rabbits, J Am Coll Cardiol, 2003;41:858-69.
39. Van Wagoner DR, Pond AL, McCarthy PM, et al., Outward K+ current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation, Circ Res, 1997;80:772-81.
40. Voigt N, Maguy A, Yeh YH, et al., Changes in I K, ACh single-channel activity with atrial tachycardia remodelling in canine atrial cardiomyocytes, Cardiovasc Res, 2008;77:35-43.
41. Voigt N, Trausch A, Knaut M, et al., Left-to-right atrial inward-rectifier potassium current gradients in patients with paroxysmal versus chronic atrial fibrillation, Circ Arrhythm Electrophysiol, 2010;3(5):472-80.
42. Brundel BJ, Van Gelder IC, Henning RH, et al. Ion channel remodeling is related to intraoperative atrial effective refractory periods in patients with paroxysmal and persistent atrial fibrillation, Circulation, 2001;103:684-90.
43. Yue L, Melnyk P, Gaspo R, et al., Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation, Circ Res, 1999;84:776-84.
44. Klein G, Schröder F, Vogler D, et al., Increased open probability of single cardiac L-type calcium channels in patients with chronic atrial fibrillation. Role of phosphatase 2A, Cardiovasc Res, 2003;59:37-45.
45. Schotten U, Haase H, Frechen D, et al., The L-type Ca2+-channel subunits alpha1C and beta2 are not downregulated in atrial myocardium of patients with chronic atrial fibrillation, J Mol Cell Cardiol, 2003;35:437-43.
46. Greiser M, Halaszovich CR, Frechen D, et al., Pharmacological evidence for altered src kinase regulation of I (Ca,L) in patients with chronic atrial fibrillation, Naunyn Schmiedebergs Arch Pharmacol, 2007;375:383-92.
47. El-Armouche A, Boknik P, Eschenhagen T, et al., Molecular determinants of altered Ca2+ handling in human chronic atrial fibrillation, Circulation, 2006;114:670-80.
48. Carnes CA, Janssen PM, Ruehr ML, et al., Atrial glutathione content, calcium current, and contractility, J Biol Chem, 2007;282:28063-73.
49. Grammer JB, Zeng X, Bosch RF, et al., Atrial L-type Ca2+-channel, beta-adrenorecptor, and 5-hydroxytryptamine type 4 receptor mRNAs in human atrial fibrillation, Basic Res Cardiol, 2001;96:82-90.
50. Dobrev D, Ravens U, Remodeling of cardiomyocyte ion channels in human atrial fibrillation, Basic Res Cardiol, 2003;98:137-48
51. Christ T, Wettwer E, Voigt N, et al., Pathology-specific effects of the IKur/Ito/IK,ACh blocker AVE0118 on ion channels in human chronic atrial fibrillation, Br J Pharmacol, 2008;154:1619-30.
52. Brundel BJ, Ausma J, van Gelder IC, et al. Activation of proteolysis by calpains and structural changes in human paroxysmal and persistent atrial fibrillation, Cardiovasc Res, 2002;54:380-89.
53. Goette A, Arndt M, Rocken C, et al., Calpains and cytokines in fibrillating human atria, Am J Physiol Heart Circ Physiol, 2002;283:H264-72.
54. Chelu MG, Sarma S, Sood S, et al., Calmodulin kinase II-mediated sarcoplasmic reticulum Ca2+ leak promotes atrial fibrillation in mice, J Clin Invest, 2009;119:1940-51.
55. Tessier S, Karczewski P, Krause EG, et al., Regulation of the transient outward K(+) current by Ca(2+)/calmodulindependent protein kinases II in human atrial myocytes, Circ Res, 1999;85:810-9.
56. Rossow CF, Dilly KW, Santana LF, Differential calcineurin/NFATc3 activity contributes to the Ito transmural gradient in the mouse heart, Circ Res, 2006;98:1306-13
57. Bukowska A, Lendeckel U, Hirte D, et al., Activation of the calcineurin signaling pathway induces atrial hypertrophy during atrial fibrillation, Cell Mol Life Sci, 2006;63:333-42.
58. Courtemanche M, Ramirez RJ, Nattel S, Ionic targets for drug therapy and atrial fibrillation-induced electrical remodeling: insights from a mathematical model, Cardiovasc Res, 1999;42:477-89
59. Wettwer E, Hála O, Christ T, et al., Role of IKur in controlling action potential shape and contractility in the human atrium: influence of chronic atrial fibrillation, Circulation, 2004;110:2299-306.
60. Brandt MC, Priebe L, Bohle T, et al., The ultrarapid and the transient outward K(+) current in human atrial fibrillation. Their possible role in postoperative atrial fibrillation, J Mol Cell Cardiol, 2000;32:1885-96.
61. Grammer JB, Bosch RF, Kuhlkamp V, et al., Molecular remodeling of Kv4.3 potassium channels in human atrial fibrillation, J Cardiovasc Electrophysiol, 2000;11:626-33.
62. Workman AJ, Kane KA, Rankin AC, The contribution of ionic currents to changes in refractoriness of human atrial myocytes associated with chronic atrial fibrillation, Cardiovasc Res, 2001;52:226-35
63. Brundel BJ, Van Gelder IC, Henning RH, et al. Alterations in potassium channel gene expression in atria of patients with persistent and paroxysmal atrial fibrillation: differential regulation of protein and mRNA levels for K+ channels, J Am Coll Cardiol, 2001;37:926-32.
64. Ellinghaus P, Scheubel RJ, Dobrev D, et al., Comparing the global mRNA expression profile of human atrial and ventricular myocardium with high-density oligonucleotide arrays, J Thorac Cardiovasc Surg, 2005;129:1383-90.
65. Dudley SC, Jr., Hoch NE, McCann LA, et al., Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases, Circulation, 2005;112:1266-73.
66. Kim YM, Guzik TJ, Zhang YH, et al., A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation, Circ Res, 2005;97:629-36.
67. Núñez L, Vaquero M, Gomez R, et al., Nitric oxide blocks hKv1.5 channels by S-nitrosylation and by a cyclic GMPdependent mechanism, Cardiovasc Res, 2006;72:80-9.
68. Caballero R, de la Fuente MG, Gómez R, et al. In humans, chronic atrial fibrillation decreases the transient outward current and ultrarapid component of the delayed rectifier current differentially on each atria and increases the slow component of the delayed rectifier current in both, J Am Coll Cardiol, 2010;55:2346-54.
69. Dobrev D, Wettwer E, Kortner A, et al., Human inward rectifier potassium channels in chronic and postoperative atrial fibrillation, Cardiovasc Res, 2002;54:397-404.
70. Cha TJ, Ehrlich JR, Zhang L, et al., Atrial tachycardia remodeling of pulmonary vein cardiomyocytes: comparison with left atrium and potential relation to arrhythmogenesis, Circulation, 2005;111:728-35.
71. Cha TJ, Ehrlich JR, Zhang L, et al., Atrial ionic remodeling induced by atrial tachycardia in the presence of congestive heart failure, Circulation, 2004;110:1520-6.
72. Girmatsion Z, Biliczki P, Bonauer A, et al., Changes in microRNA-1 expression and IK1 up-regulation in human atrial fibrillation, Heart Rhythm, 2009;6:1802-9.
73. Karle CA, Zitron E, Zhang W, et al., Human cardiac inwardlyrectifying K+ channel Kir(2.1b) is inhibited by direct protein kinase C-dependent regulation in human isolated cardiomyocytes and in an expression system, Circulation, 2002;106:1493-9.
74. Yang B, Lin H, Xiao J, et al., The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2, Nat Med, 2007;13:486-91.
75. Kneller J, Zou R, Vigmond EJ, et al., Cholinergic atrial fibrillation in a computer model of a two-dimensional sheet of canine atrial cells with realistic ionic properties, Circ Res, 2002;90:E73-87.
76. Kovoor P, Wickman K, Maguire CT, et al., Evaluation of the role of I(KACh) in atrial fibrillation using a mouse knockout model, J Am Coll Cardiol, 2001;37:2136-43.
77. Dobrev D, Wettwer E, Himmel HM, et al., G-Protein beta(3)-subunit 825T allele is associated with enhanced human atrial inward rectifier potassium currents, Circulation, 2000;102:692-7.
78. Himmel HM, Meyer Zu Heringdorf D, et al. Evidence for Edg-3 receptor-mediated activation of I(K.ACh) by sphingosine-1-phosphate in human atrial cardiomyocytes, Mol Pharmacol, 2000;58:449-54.
79. Nikolov EN, Ivanova-Nikolova TT, Coordination of membrane excitability through a GIRK1 signaling complex in the atria, J Biol Chem, 2004;279:23630-6
80. Voigt N, Makary S, Nattel S, et al., Voltage-clamp-based methods for the detection of constitutively active acetylcholine-gated IK,ACh channels in the diseased heart, Methods Enzymol, 2010;484:653-75.
81. Makary S, Maguy A, Wakili R, et al., Mechanisms underlying activation of constitutive acetylcholine-regulated potassium channels by atrial tachycardia remodeling, Circulation, 2009;120:S664.
82. Wu G, Huang CX, Tang YH, et al., ATP current density and allosteric modulation during chronic atrial fibrillation, Chin Med J (Engl), 2005;118:1161-6.
83. Balana B, Dobrev D, Wettwer E, et al., Decreased ATPsensitive K(+) current density during chronic human atrial fibrillation, J Mol Cell Cardiol, 2003;35:1399-405.
84. Akar FG, Spragg DD, Tunin RS, et al., Mechanisms underlying conduction slowing and arrhythmogenesis in nonischemic dilated cardiomyopathy, Circ Res, 2004;95:717-25.
85. Akar FG, Nass RD, Hahn S, et al., Dynamic changes in conduction velocity and gap junction properties during development of pacing-induced heart failure, Am J Physiol Heart Circ Physiol, 2007;293:H1223-30.
86. Dhein S, Hagen A, Jozwiak J, et al., Improving cardiac gap junction communication as a new antiarrhythmic mechanism: the action of antiarrhythmic peptides, Naunyn Schmiedebergs Arch Pharmacol, 2010;381:221-34.
87. Wetzel U, Boldt A, Lauschke J, et al., Expression of connexins 40 and 43 in human left atrium in atrial fibrillation of different aetiologies, Heart, 2005;91:166-70.
88. Nishida K, Michael G, Dobrev D, et al., Animal models for atrial fibrillation: clinical insights and scientific opportunities, Europace, 2010;12:160-72.
89. Ausma J, van der Velden HM, Lenders MH, et al. Reverse structural and gap-junctional remodeling after prolonged atrial fibrillation in the goat, Circulation, 2003;107:2051-8.
90. Firouzi M, Ramanna H, Kok B, et al., Association of human connexin40 gene polymorphisms with atrial vulnerability as a risk factor for idiopathic atrial fibrillation, Circ Res, 2004;95:e29-33.
91. Gollob MH, Jones DL, Krahn AD, et al., Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation, N Engl J Med, 2006;354:2677-88.
92. Juang JM, Chern YR, Tsai CT, et al., The association of human connexin 40 genetic polymorphisms with atrial fibrillation, Int J Cardiol, 2007;116:107-12.
93. Nishida M, Kurose H, Roles of TRP channels in the development of cardiac hypertrophy, Naunyn Schmiedebergs Arch Pharmacol, 2008;378:395-406
94. Watanabe H, Pathological role of TRP channels in cardiovascular and respiratory diseases, Nippon Yakurigaku Zasshi, 2009;134:127-30
95. Van Wagoner DR, Voigt N, Bunnell B, et al., Transient receptor potential canonical (TRPC) channel subunit remodeling in clinical and experimental AF, Heart Rhythm, 2009;6:PO06-77.
96. Ellinor PT, Lunetta KL, Glazer NL, et al., Common variants in KCNN3 are associated with lone atrial fibrillation, Nat Genet, 2010;42:240-4.
97. Xu Y, Tuteja D, Zhang Z, et al., Molecular identification and functional roles of a Ca(2+)-activated K+ channel in human and mouse hearts, J Biol Chem, 2003;278:49085-94.
98. Ozgen N, Dun W, Sosunov EA, et al., Early electrical remodeling in rabbit pulmonary vein results from trafficking of intracellular SK2 channels to membrane sites, Cardiovasc Res, 2007;75:758-69.
99. Li N, Timofeyev V, Tuteja D, et al., Ablation of a Ca2+-activated K+ channel (SK2 channel) results in action potential prolongation in atrial myocytes and atrial fibrillation, J Physiol, 2009;587:1087-100.
100. Hove-Madsen L, Llach A, Bayes-Genis A, et al., Atrial fibrillation is associated with increased spontaneous calcium release from the sarcoplasmic reticulum in human atrial myocytes, Circulation, 2004;110:1358-63.
101. Vest JA, Wehrens XH, Reiken SR, et al., Defective cardiac ryanodine receptor regulation during atrial fibrillation, Circulation, 2005;111:2025-32.
102. Liang X, Xie H, Zhu PH, et al., Ryanodine receptor-mediated Ca2+ events in atrial myocytes of patients with atrial fibrillation, Cardiology, 2008;111:102-10.
103. Neef S, Dybkova N, Sossalla S, et al., CaMKII-dependent diastolic SR Ca2+ leak and elevated diastolic Ca2+ levels in right atrial myocardium of patients with atrial fibrillation, Circ Res, 2010:106(6):1134-44.
104. Voigt N, Traffords AW, Ravens U, et al., Increased diastolic sarcoplasmic reticulum calcium leak may contribute to arrhythmogenesis in patients with atrial fibrillation, Cardiovasc Res, 2010;87:S53.
105. Voigt N, Trafford AW, Ravens U, et al., Cellular and molecular determinants of altered atrial Ca2+ signaling in patients with chronic atrial fibrillation, Circulation, 2009;120:S667-8.
106. Dobrev D, Atrial Ca2+ signaling in atrial fibrillation as an antiarrhythmic drug target, Naunyn Schmiedebergs Arch Pharmacol, 2010;381:195-206
107. Dobrev D, Teos LY, Lederer WJ, Unique atrial myocyte Ca2+ signaling, J Mol Cell Cardiol, 2009;46:448-51
108. Wehrens XH, Lehnart SE, Reiken SR, et al., Ca2+/calmodulindependent protein kinase II phosphorylation regulates the cardiac ryanodine receptor, Circ Res, 2004;94:e61-70.
109. Sood S, Chelu MG, van Oort RJ, et al. Intracellular calcium leak due to FKBP12.6 deficiency in mice facilitates the inducibility of atrial fibrillation, Heart Rhythm, 2008;5:1047-54.
110. Lenaerts I, Bito V, Heinzel FR, et al., Ultrastructural and functional remodeling of the coupling between Ca2+ influx and sarcoplasmic reticulum Ca2+ release in right atrial myocytes from experimental persistent atrial fibrillation, Circ Res, 2009;105:876-85.
111. Li X, Zima AV, Sheikh F, et al., Endothelin-1-induced arrhythmogenic Ca2+ signaling is abolished in atrial myocytes of inositol-1,4,5-trisphosphate(IP3)-receptor type 2-deficient mice, Circ Res, 2005;96:1274-81.
112. Zhao ZH, Zhang HC, Xu Y, et al., Inositol-1,4,5-trisphosphate and ryanodine-dependent Ca2+ signaling in a chronic dog model of atrial fibrillation, Cardiology, 2007;107:269-76.
113. Nattel S, Atrial electrophysiological remodeling caused by rapid atrial activation: underlying mechanisms and clinical relevance to atrial fibrillation, Cardiovasc Res, 1999;42:298-308
114. Fynn SP, Todd DM, Hobbs WJ, et al., Clinical evaluation of a policy of early repeated internal cardioversion for recurrence of atrial fibrillation, J Cardiovasc Electrophysiol, 2002;13:135-41.
115. Tse HF, Wang Q, Yu CM, et al., Time course of recovery of left atrial mechanical dysfunction after cardioversion of spontaneous atrial fibrillation with the implantable atrial defibrillator, Am J Cardiol, 2000;86:1023-5, A10.
116. Tse HF, Lau CP, Yu CM, et al., Effect of the implantable atrial defibrillator on the natural history of atrial fibrillation, J Cardiovasc Electrophysiol, 1999;10:1200-9.
117. Timmermans C, Lévy S, Ayers GM, et al., Spontaneous episodes of atrial fibrillation after implantation of the Metrixepisodes. Metrix Investigators, J Am Coll Cardiol, 2000;35:1428-33
118. Fareh S, Bénardeau A, Thibault B, et al., The T-type Ca(2+) channel blocker mibefradil prevents the development of a substrate for atrial fibrillation by tachycardia-induced atrial remodeling in dogs, Circulation, 1999;100:2191-7.
119. Shinagawa K, Shiroshita-Takeshita A, Schram G, et al., Effects of antiarrhythmic drugs on fibrillation in the remodeled atrium: insights into the mechanism of the superior efficacy of amiodarone, Circulation, 2003;107:1440-6.
120. Dobrev D, Cardiomyocyte Ca2+ overload in atrial tachycardia: is blockade of L-type Ca2+ channels a promising approach to prevent electrical remodeling and arrhythmogenesis?, Naunyn Schmiedebergs Arch Pharmacol, 2007;376:227-30
121. Nishida K, Fujiki A, Sakamoto T, et al., Bepridil reverses atrial electrical remodeling and L-type calcium channel downregulation in a canine model of persistent atrial tachycardia, J Cardiovasc Electrophysiol, 2007;18:765-72.
122. Pandit SV, Berenfeld O, Anumonwo JM, et al., Ionic determinants of functional reentry in a 2-D model of human atrial cells during simulated chronic atrial fibrillation, Biophys J, 2005;88:3806-21.
123. Dobrev D, Wehrens XH, Calmodulin kinase II, sarcoplasmic reticulum Ca2+ leak, and atrial fibrillation, Trends Cardiovasc Med, 2010;20:30-4
124. Neuman RB, Bloom HL, Shukrullah I, et al., Oxidative stress markers are associated with persistent atrial fibrillation, Clin Chem, 2007;53:1652-7.
125. Shiroshita-Takeshita A, Brundel BJ, Lavoie J, et al., Prednisone prevents atrial fibrillation promotion by atrial tachycardia remodeling in dogs, Cardiovasc Res, 2006;69:865-75.
126. Shiroshita-Takeshita A, Schram G, Lavoie J, et al., Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs, Circulation, 2004;110:2313-9.
127. Issac TT, Dokainish H, Lakkis NM, Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data, J Am Coll Cardiol, 2007;50:2021-8
128. Dernellis J, Panaretou M, Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation, Eur Heart J, 2004;25:1100-7